Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000913414-05-000629
Filing Date
2005-02-14
Accepted
2005-02-14 15:28:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 ligandpharm123104.txt SC 13G 64939
  Complete submission text file 0000913414-05-000629.txt   67191
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-43329 | Film No.: 05609253
SIC: 2834 Pharmaceutical Preparations

Mailing Address 45 FREMONT ST SAN FRANCISCO CA 94105
Business Address 45 FREMONT ST 17TH FL SAN FRANCISCO CA 94105 4155972639
BARCLAYS GLOBAL INVESTORS NA /CA/ (Filed by) CIK: 0000913414 (see all company filings)

EIN.: 943112180 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000